Bibliographic Details
| Title: |
Drug-resistance mechanisms and tuberculosis drugs. |
| Authors: |
Köser, Claudio U., Javid, Babak, Liddell, Kathleen, Ellington, Matthew J., Feuerriegel, Silke, Niemann, Stefan, Brown, Nicholas M., Burman, William J., Abubakar, Ibrahim, Ismail, Nazir A., Moore, David, Peacock, Sharon J., Török, M. Estée |
| Source: |
Lancet. 1/24/2015, Vol. 385 Issue 9965, p305-307. 3p. 1 Color Photograph. |
| Subjects: |
Multidrug-resistant tuberculosis, Multidrug resistance in bacteria, Drug development, Antibiotics, Gene patents |
| Abstract: |
The authors focus on ways to ensure that research on the genetic basis of multidrug-resistant tuberculosis (TB) occurs in a timely way. Topics discussed include linking the elucidation of resistance mechanisms to the approval process for new antibiotics, resistance to bedaquiline and clofazimine, and minimizing the chance of developing less effective antibiotics. Also mentioned are concerns about patenting resistance mechanisms and the legality of patenting isolated genes in many nations. |
| Database: |
Psychology and Behavioral Sciences Collection |
